This inventor holds 1 USPTO granted patent. Top assignee: The University of Tokyo. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Harumichi Ishigame: Innovator in Autoimmune Disease Therapy
Introduction
Harumichi Ishigame is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents for autoimmune diseases. His innovative work has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Ishigame holds a patent for CTRP6, which can be utilized as a therapeutic and prophylactic agent for autoimmune diseases. The patent provides methods for suppressing the complement alternative pathway in a mammalian subject in need. This involves administering a therapeutically effective amount of C1q and tumor necrosis factor-related protein 6 (CTRP6) or a functional analog thereof.
Career Highlights
Harumichi Ishigame is affiliated with The University of Tokyo, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating autoimmune conditions.
Collaborations
Ishigame has collaborated with notable colleagues, including Yoichiro Iwakura and Masanori Murayama, to advance research in his area of expertise.
Conclusion
Harumichi Ishigame's contributions to the field of autoimmune disease therapy through his patent on CTRP6 highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile